Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (CHARGE-CHS) C self-report, ICD-9, medications PO 107 (45%) 3164 (61%) 73 (5) - - - 72 (5) - 9,655

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs2038208 chr22:41585793 EP300 [+9712bp] G vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 8 (0-46) 7.16e-05
rs4822016 chr22:41586320 EP300 [+10239bp] T vs. C All: C 15 108,990 - - 0.94 (0.91-0.97) 9 (0-47) 9.15e-05
rs5758257 chr22:41593636 L3MBTL2 [-7573bp] G vs. A All: C 15 108,990 0.292 (G) - 1.07 (1.03-1.10) 8 (0-45) 8.41e-05
rs5751061 chr22:41593873 L3MBTL2 [-7336bp] T vs. G All: C 15 108,990 0.317 (T) 0.175 (T) 1.07 (1.03-1.10) 8 (0-45) 8.41e-05
rs2038209 chr22:41594611 L3MBTL2 [-6598bp] T vs. C All: C 15 108,990 0.3 (T) 0.158 (T) 1.07 (1.03-1.10) 8 (0-45) 8.48e-05
rs136401 chr22:41596010 L3MBTL2 [-5199bp] A vs. C All: C 15 108,990 0.3 (A) 0.15 (A) 1.07 (1.03-1.10) 8 (0-45) 8.19e-05
rs5751062 chr22:41598053 L3MBTL2 [-3156bp] C vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 6 (0-57) 5.70e-05
rs139431 chr22:41604353 L3MBTL2 T vs. C All: C 15 108,990 0.283 (T) 0.167 (T) 1.07 (1.03-1.10) 8 (0-45) 9.30e-05
rs4820432 chr22:41604399 L3MBTL2 A vs. G All: C 15 108,990 - - 0.94 (0.91-0.97) 9 (0-46) 8.97e-05
rs139432 chr22:41604557 L3MBTL2 A vs. G All: C 15 108,990 0.292 (A) 0.167 (A) 1.07 (1.03-1.10) 8 (0-45) 9.35e-05
rs139434 chr22:41604785 L3MBTL2 G vs. A All: C 15 108,990 0.292 (G) 0.133 (G) 1.07 (1.04-1.11) 17 (0-54) 6.01e-05
rs139435 chr22:41604811 L3MBTL2 A vs. G All: C 15 108,990 0.292 (A) 0.15 (A) 1.07 (1.04-1.11) 17 (0-54) 6.02e-05
rs139436 chr22:41605131 L3MBTL2 G vs. A All: C 15 108,990 - - 0.93 (0.90-0.96) 19 (0-56) 3.89e-05
rs139437 chr22:41605635 L3MBTL2 C vs. T All: C 15 108,990 0.292 (C) 0.167 (C) 1.08 (1.04-1.11) 14 (0-52) 4.52e-05
rs139439 chr22:41606030 L3MBTL2 C vs. A All: C 15 108,990 0.292 (C) 0.167 (C) 1.07 (1.03-1.10) 11 (0-48) 8.96e-05
rs7290378 chr22:41606195 L3MBTL2 C vs. T All: C 15 108,990 0.267 (C) 0.167 (C) 1.07 (1.03-1.10) 10 (0-48) 9.49e-05
rs7289286 chr22:41606264 L3MBTL2 A vs. G All: C 15 108,990 - - 0.94 (0.91-0.97) 14 (0-51) 1.03e-04
rs7289294 chr22:41606279 L3MBTL2 A vs. G All: C 15 108,990 - - 0.94 (0.90-0.97) 15 (0-52) 9.65e-05
rs7290545 chr22:41606312 L3MBTL2 T vs. C All: C 15 108,990 - - 0.94 (0.91-0.97) 10 (0-47) 9.95e-05
rs7289861 chr22:41606397 L3MBTL2 G vs. A All: C 15 108,990 - - 0.93 (0.90-0.97) 14 (0-52) 5.68e-05
rs5758262 chr22:41606720 L3MBTL2 G vs. A All: C 15 108,990 - - 0.94 (0.91-0.97) 13 (0-51) 9.53e-05
rs139440 chr22:41606988 L3MBTL2 G vs. A All: C 15 108,990 0.292 (G) 0.15 (G) 1.07 (1.03-1.10) 10 (0-47) 9.71e-05
rs139441 chr22:41607056 L3MBTL2 G vs. A All: C 15 108,990 0.292 (G) 0.158 (G) 1.07 (1.03-1.10) 10 (0-48) 9.47e-05
rs8141477 chr22:41608629 L3MBTL2 G vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 13 (0-51) 7.36e-05
rs12169035 chr22:41608948 L3MBTL2 T vs. C All: C 15 108,990 0.292 (T) 0.15 (T) 1.07 (1.03-1.10) 11 (0-49) 7.54e-05
rs139447 chr22:41609430 L3MBTL2 A vs. G All: C 15 108,990 0.292 (A) 0.167 (A) 1.07 (1.03-1.10) 11 (0-48) 8.67e-05
rs139448 chr22:41609443 L3MBTL2 T vs. C All: C 15 108,990 0.292 (T) 0.167 (T) 1.07 (1.03-1.10) 11 (0-49) 8.77e-05
rs139451 chr22:41610024 L3MBTL2 A vs. G All: C 15 108,990 0.292 (A) 0.15 (A) 1.07 (1.03-1.10) 11 (0-49) 9.82e-05
rs139456 chr22:41610449 L3MBTL2 G vs. A All: C 14 106,157 0.292 (G) 0.15 (G) 1.07 (1.04-1.11) 14 (0-52) 6.87e-05
rs139457 chr22:41610667 L3MBTL2 C vs. T All: C 15 108,990 0.3 (C) 0.117 (C) 1.08 (1.04-1.12) 18 (0-55) 5.43e-05
rs139458 chr22:41610668 L3MBTL2 A vs. G All: C 15 108,990 0.3 (A) 0.117 (A) 1.08 (1.04-1.12) 18 (0-55) 5.43e-05
rs62238732 chr22:41611708 L3MBTL2 A vs. G All: C 15 108,990 - - 0.92 (0.89-0.96) 19 (0-55) 6.68e-05
rs85220 chr22:41612965 L3MBTL2 G vs. T All: C 15 108,990 0.283 (G) 0.15 (G) 1.07 (1.03-1.10) 8 (0-45) 8.17e-05
rs139470 chr22:41616516 L3MBTL2 C vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 12 (0-50) 8.72e-05
rs139475 chr22:41623996 L3MBTL2 T vs. C All: C 15 108,990 0.292 (T) 0.167 (T) 1.07 (1.04-1.11) 7 (0-43) 5.70e-05
rs139478 chr22:41624761 L3MBTL2 G vs. A All: C 15 108,990 - - 0.94 (0.91-0.97) 8 (0-45) 5.21e-05
rs3721 chr22:41627073 L3MBTL2 T vs. C All: C 15 108,990 0.292 (T) 0.167 (T) 1.07 (1.03-1.10) 11 (0-48) 6.47e-05
rs139484 chr22:41627543 CHADL G vs. T All: C 15 108,990 0.292 (G) 0.167 (G) 1.07 (1.03-1.10) 11 (0-48) 6.11e-05
rs139485 chr22:41627606 CHADL A vs. G All: C 15 108,990 0.292 (A) 0.158 (A) 1.07 (1.03-1.10) 8 (0-44) 6.57e-05
rs139492 chr22:41628902 CHADL T vs. G All: C 15 108,990 0.283 (T) 0.108 (T) 1.07 (1.03-1.10) 0 (0-52) 9.04e-05
rs139493 chr22:41632079 CHADL C vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 2 (0-55) 1.06e-04
rs5768983 chr22:46978375 GRAMD4 C vs. T All: C 14 105,041 0.4 (C) 0.108 (T) 0.93 (0.90-0.96) 0 (0-22) 1.40e-05
rs5768984 chr22:46978776 GRAMD4 G vs. A All: C 14 105,041 0.417 (G) 0.108 (A) 0.93 (0.90-0.96) 0 (0-22) 1.62e-05
rs5768985 chr22:46978958 GRAMD4 A vs. G All: C 14 105,041 0.417 (A) - 0.93 (0.90-0.96) 0 (0-21) 1.41e-05
rs5767275 chr22:46981234 GRAMD4 C vs. T All: C 15 108,990 - - 1.09 (1.05-1.12) 0 (0-25) 1.44e-06
rs5767281 chr22:46986889 GRAMD4 A vs. G All: C 15 108,990 0.367 (A) 0.125 (G) 0.92 (0.89-0.95) 0 (0-27) 5.21e-07
rs8142773 chr22:46993449 GRAMD4 T vs. C All: C 15 108,990 - - 1.07 (1.04-1.11) 0 (0-47) 2.58e-05
rs10220344 chrY:19917246 RNU1-128P [+16204bp] T vs. C All: C 15 108,990 - - 1.15 (1.10-1.20) 34 (0-64) 2.39e-10
rs11626155 chrY:19917330 RNU1-128P [+16288bp] C vs. T All: C 15 108,990 - - 1.11 (1.06-1.16) 34 (0-65) 2.32e-06
rs62184162 chrY:23228806 intergenic T vs. C All: C 15 108,990 - - 1.09 (1.04-1.13) 0 (0-42) 6.18e-05